Talented young investigators researching MS can apply themselves or nominate others in the field for the Rogier Hintzen Talent Award 2021. The award is a posthumous tribute to Professor of Multiple Sclerosis Rogier Hintzen who worked at Erasmus MC and passed away in 2019.
Incentive Award
The Department of Neurology at Erasmus MC and Rogier’s wife Eleonoor present the Rogier Hintzen Talent Award yearly, during a 12 year period. This covers the time during which Rogier would have been still employed. The award includes an incentive prize of 3,000 euros for research within the MS field.
Criteria and procedure
The second Rogier Hintzen Award will be presented on Wednesday September 29th 2021 at the Sociëteit De Maas in Rotterdam. You can apply until August 29th 2021. For more information, read the criteria and procedure in this attachment.
Winner
Dr. Karim Kreft was the winner of the first Rogier Hintzen Talent Award in 2020. He was praised by the jury for his track record in patient-related research into the causes and better treatment of MS. His research focuses mainly on the immunological consequences of genetic abnormalities in MS patients.
ErasMS
ErasMS, the Rotterdam center for MS and inflammation of the central nervous system, was established in 2002 thanks to Hintzen’s efforts. Rogier Hintzen died of pancreatic cancer in 2019 at the age of 56 and had many ideas for new research into MS. The Erasmus MC Foundation wants to pursue his scientific dream of finding out through research what role T-cells play in the development of MS. The Talent Award was also created to stimulate and reward young research talent in the field of MS from all over the Netherlands.
Multiple Sclerosis
Multiple Sclerosis (MS) is a debilitating and debilitating disease that occurs mostly in young people. Children can also develop MS. In adults, the first symptoms show up when people are between 20 and 40 years old. MS is a neurological disease with many different features. How the disease develops is often unpredictable. MS is a progressive disease. This means that people get sicker and sicker and lose more and more functions. MS is the most disabling disease among young people. In the Netherlands about 17,000 people have MS. About 800 people are added to this number every year. There is currently no medicine to cure MS.
